Episode 439: Cancer Therapy for Noncancer Indications: Gene Therapies
From The ONS Podcast · · 39 min
This plays from the publisher's own server. We do not host a copy.
Description
"With the gene therapy itself, we collect the patient's own hematopoietic stem cells and modify them outside the body. The other approach is using a lentiviral therapy, which uses an inactivated virus to add a healthy gene, so the cells produce functional hemoglobin. While gene therapy looks a lot like an autologous stem cell transplant, the key difference is that the cells are genetically modified before they're returned to the patient," Tia T. Wheatley, DNP, RN, AGACNP-BC, TCTCN™, nurse practitioner in hematology and oncology at UCLA Health in Los Angeles, CA, told Madeline Johnston, MSN, RN, OCN®, oncology clinical specialist at ONS, during a conversation about gene therapies for sickle cell disease. Johnston also spoke to ONS member Michelle Cha, MS, BSN, RN, clinical research nurse at the Centers for Bleeding Disorders at Georgetown University Medical Center in Washington, DC, about gene therapy for hemophilia.
Music Credit: "Fireflies and Stardust (http://www.incompetech.com/)" by Kevin MacLeod
Licensed under Creative Commons by Attribution 3.0
Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by October 30, 2027. Michelle Cha reported financial relationships with HemaBiologics, Sanofi, Acumetis Global, and Bayer, as well as research funding from multiple organizations. These financial relationships have been mitigated. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Learning outcome: Learners will report an increase in knowledge related to gene therapy for noncancer indications.
Episode Notes
- Complete this evaluation for free NCPD (https://loginlr.ons.org/sso/jwt/redirect/token?apikey=c27fb796-f5bd-43e6-91aa-59f080be0a44&jwtapp=lpuserservice&ui_locales=ons&return_url=https://login-services.ons.org/api/HttpTriggerLPuserServiceRedirect?alias=PE439).
- ONS Podcast™ episodes:
- Episode 433: Cancer Treatments for Noncancer Indications: Chemotherapy/Immunotherapy (https://www.ons.org/education-hub/oncology-nursing-podcast/episode-433-cancer-treatments-noncancer-indications-chemotherapyimmunotherapy)
- Episode 416: Cancer Treatments for Noncancer Indications: Radiation (https://www.ons.org/education-hub/oncology-nursing-podcast/episode-416-cancer-treatments-noncancer-indications-radiation)
- Episode 288: Pharmacology 101: Antimetabolites (https://www.ons.org/education-hub/oncology-nursing-podcast/episode-288-pharmacology-101-antimetabolites)
- Episode 286: Pharmacology 101: Alkylating Agents (https://www.ons.org/education-hub/ons-podcast)
- Episode 208: How to Have Fertility Preservation Conversations With Your Patients (https://www.ons.org/education-hub/oncology-nursing-podcast/episode-208-how-have-fertility-preservation-conversations)
- Episode 173: Oncology Nurses' Role in Stem Cell Transplants for Pediatric Sickle Cell Disease (https://www.ons.org/education-hub/oncology-nursing-podcast/episode-173-oncology-nurses-role-stem-cell-transplants)
- ONS Voice articles:
- Adherence to Recommended Oral Hygiene Can Help Prevent Oral Mucositis in Patients With Cancer (https://www.ons.org/publications-research/voice/news-views/11-2025/adherence-recommended-oral-hygiene-can-help-prevent)
- FDA Approves First Adenoviral Vector-Based Gene Therapy for High-Risk, BCG Unresponsive, Non–Muscle-Invasive Bladder Cancer (https://www.ons.org/publications-research/voice/news-views/12-2022/fda-approves-first-adenoviral-vector-based-gene)
- Fertility Preservation Protects Possibilities for Patients With Cancer (https://www.ons.org/publications-research/voice/news-views/06-2025/fertility-preservation-protects-possibilities)
- New NIH Program Aims to Increase Gene Therapies for Rare Diseases (https://www.ons.org/publications-research/voice/advocacy/11-2021/new-nih-program-aims-increase-gene-therapies-rare)
-…